Molecular mechanisms encoding quantitative and qualitative traits of prion strains

Prions and Diseases: Volume 1, Physiology and Pathophysiology

Volumn , Issue , 2013, Pages 161-179

  Safar, Jiri G ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Conformation of prion protein; Conformation dependent immunoassay (CDI); Neurodegeneration; Prion strains; Protein misfolding cyclic amplification (PMCA)

Indexed keywords

EID: 84948128478     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-5305-5     Document Type: Chapter

References (126)

1. Anfinsen CB (1973) Principles that govern the folding of protein chains. Science 181:223-230.
2. Barria MA, Mukherjee A, Gonzalez-Romero D, Morales R, Soto C (2009) De novo generation of infectious prions in vitro produces a new disease phenotype. PLoS Pathog 5:e1000421.
3. Bennett MJ, Schlunegger MP, Eisenberg D (1995) 3D domain swapping: a mechanism for oligomer assembly. Protein Sci 4:2455-2468.
4. Bergstrom AL, Jensen TK, Heegaard PM, Cordes H, Hansen VB, Laursen H et al (2006) Shortterm study of the uptake of PrP(Sc) by the Peyer’s patches in hamsters after oral exposure to scrapie. J Comp Pathol 134:126-133.
5. Bessen RA, Marsh RF (1992) Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J Virol 66:2096-2101.
6. Bessen RA, Marsh RF (1994) Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol 68:7859-7868.
7. Bishop MT, Will RG, Manson JC (2010) Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties. Proc Natl Acad Sci USA 107:12005-12010.
8. Borchelt DR, Scott M, Taraboulos A, Stahl N, Prusiner SB (1990) Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells. J Cell Biol110:743-752.
9. Brown P, Gibbs CJ Jr, Rodgers-Johnson P, Asher DM, Sulima MP, Bacote A et al (1994) Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 35:513-529.
10. Browning SR, Mason GL, Seward T, Green M, Eliason GA, Mathiason C et al (2004) Transmission of prions from mule deer and elk with chronic wasting disease to transgenic mice expressing cervid PrP. J Virol 78:13345-13350.
11. Bruce ME, Dickinson AG (1979) Biological stability of different classes of scrapie agent. In: Prusiner SB, Hadlow WJ (eds) Slow transmissible diseases of the nervous system, vol 2. Academic, New York, pp 71-86.
12. Bruce ME, Dickinson AG (1987) Biological evidence that the scrapie agent has an independent genome. J Gen Virol 68:79-89.
13. Büeler H, Aguzzi A, Sailer A, Greiner R A, Autenried P, Aguet M et al (1993) Mice devoid of PrP are resistant to scrapie. Cell 73:1339-1347.
14. Cali I, Castellani R, Alshekhlee A, Cohen Y, Blevins J, Yuan J et al (2009) Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: its effect on the phenotype and prion-type characteristics. Brain 132:2643-2658.
15. Carlson GA, Ebeling C, Yang S-L, Telling G, Torchia M, Groth D et al (1994a) Prion isolate specified allotypic interactions between the cellular and scrapie prion proteins in congenic and transgenic mice. Proc Natl Acad Sci USA 91:5690-5694.
16. Carlson GA, DeArmond SJ, Torchia M, Westaway D, Prusiner SB (1994b) Genetics of prion diseases and prion diversity in mice. Philos Trans R Soc Lond B Biol Sci 343:363-369.
17. Castilla J, Saa P, Hetz C, Soto C (2005) In vitro generation of infectious scrapie prions. Cell121:195-206.
18. Caughey B, Raymond GJ (1991) The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. J Biol Chem 266:18217-18223.
19. Caughey B, Raymond GJ, Bessen RA (1998) Strain-dependent differences in b-sheet conformations of abnormal prion protein. J Biol Chem 273:32230-32235.
20. Caughey B, Baron GS, Chesebro B, Jeffrey M (2009) Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions. Annu Rev Biochem 78:177-204.
21. Chandler RL (1961) Encephalopathy in mice produced by inoculation with scrapie brain material. Lancet 277:1378-1379.
22. Choi YP, Peden AH, Groner A, Ironside JW, Head MW (2011) Distinct stability states of disease-associated human prion protein identified by conformation-dependent immunoassay. J Virol 84:12030-12038.
23. Cobb NJ, Surewicz WK (2009) Prion diseases and their biochemical mechanisms. Biochemistry 48:2574-2585.
24. Cohen FE, Prusiner SB (1998) Pathologic conformations of prion proteins. Annu Rev Biochem 67:793-819.
25. Colby DW, Wain R, Baskakov IV, Legname G, Palmer CG, Nguyen HO et al (2010) Proteasesensitive synthetic prions. PLoS Pathog 6:e1000736.
26. Collinge J, Clarke AR (2007) A general model of prion strains and their pathogenicity. Science318:930-936.
27. Collinge J, Sidle KCL, Meads J, Ironside J, Hill AF (1996) Molecular analysis of prion strain variation and the aetiology of “new variant” CJD. Nature 383:685-690.
28. Collinge J, Gorham M, Hudson F, Kennedy A, Keogh G, Pal S et al (2009) Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial. Lancet Neurol8:334-344.
29. Cronier S, Gros N, Tattum MH, Jackson GS, Clarke AR, Collinge J et al (2008) Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin. Biochem J 416:297-305.
30. DeArmond SJ, Sánchez H, Yehiely F, Qiu Y, Ninchak-Casey A, Daggett V et al (1997) Selective neuronal targeting in prion disease. Neuron 19:1337-1348.
31. Deleault NR, Geoghegan JC, Nishina K, Kascsak R, Williamson RA, Supattapone S (2005)Protease-resistant prion protein amplification reconstituted with partially purified substrates and synthetic polyanions. J Biol Chem 280:26873-26879.
32. Deleault NR, Harris BT, Rees JR, Supattapone S (2007) Formation of native prions from minimal components in vitro. Proc Natl Acad Sci USA 104:9741-9746.
33. Deleault NR, Kascsak R, Geoghegan JC, Supattapone S (2010) Species-dependent differences in cofactor utilization for formation of the protease-resistant prion protein in vitro. Biochemistry49(18):3928-3934.
34. Deleault NR, Piro JR, Walsh DJ, Wang F, Ma J, Geoghegan JC et al (2012) Isolation of phosphati-dylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids. Proc Natl Acad Sci USA 109:8546-8551.
35. Dickinson AG, Fraser HG (1977) Scrapie: pathogenesis in inbred mice: an assessment of host control and response involving many strains of agent. In: ter Meulen V, Katz M (eds) Slow virus infections of the central nervous system. Springer, New York, pp 3-14.
36. Dickinson AG, Outram GW (1988) Genetic aspects of unconventional virus infections: the basis of the virino hypothesis. In: Bock G, Marsh J (eds) Novel infectious agents and the central nervous system. CIBA Foundation Symposium 135. Wiley, Chichester, pp 63-83.
37. Dickinson AG, Fraser H, Meikle VMH, Outram GW (1972) Competition between different scrapie agents in mice. Nat New Biol 237:244-245.
38. Endo T, Groth D, Prusiner SB, Kobata A (1989) Diversity of oligosaccharide structures linked to asparagines of the scrapie prion protein. Biochemistry 28:8380-8388.
39. Fraser H, Dickinson AG (1973) Scrapie in mice. Agent-strain differences in the distribution and intensity of grey matter vacuolation. J Comp Pathol 83:29-40.
40. Gambetti P, Kong Q, Zou W, Parchi P, Chen SG (2003) Sporadic and familial CJD: classification and characterisation. Br Med Bull 66:213-239.
41. Geoghegan JC, Valdes PA, Orem NR, Deleault NR, Williamson RA, Harris BT et al (2007) Selective incorporation of polyanionic molecules into hamster prions. J Biol Chem282:36341-36353.
42. Geoghegan JC, Miller MB, Kwak AH, Harris BT, Supattapone S (2009) Trans-dominant inhibition of prion propagation in vitro is not mediated by an accessory cofactor. PLoS Pathog5:e1000535.
43. Ghaemmaghami S, Phuan PW, Perkins B, Ullman J, May BC, Cohen FE et al (2007) Cell division modulates prion accumulation in cultured cells. Proc Natl Acad Sci USA 104:17971-17976.
44. CJ Jr, Gajdusek DC, Asher DM, Alpers MP, Beck E, Daniel PM et al (1968) CreutzfeldtJakob disease (spongiform encephalopathy): transmission to the chimpanzee. Science161:388-389.
45. Giles K, Glidden DV, Patel S, Korth C, Groth D, Lemus A et al (2010) Human prion strain selection in transgenic mice. Ann Neurol 68:151-161.
46. Head MW, Bunn TJ, Bishop MT, McLoughlin V, Lowrie S, McKimmie CS et al (2004) Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 19912002. Ann Neurol 55:851-859.
47. Hill AF, Desbruslais M, Joiner S, Sidle KCL, Gowland I, Collinge J et al (1997) The same prion strain causes vCJD and BSE. Nature 389:448-450.
48. Jones EM, Surewicz WK (2005) Fibril conformation as the basis of species- and strain-dependent seeding specificity of mammalian prion amyloids. Cell 121:63-72.
49. Kaneko K, Zulianello L, Scott M, Cooper CM, Wallace AC, James TL et al (1997) Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc Natl Acad Sci USA 94:10069-10074.
50. Karapetyan YE, Saa P, Mahal SP, Sferrazza GF, Sherman A, Sales N et al (2009) Prion strain discrimination based on rapid in vivo amplification and analysis by the cell panel assay. PLoS One4:e5730.
51. Kellings K, Meyer N, Mirenda C, Prusiner SB, Riesner D (1992) Further analysis of nucleic acids in purified scrapie prion preparations by improved return refocussing gel electrophoresis (RRGE). J Gen Virol 73:1025-1029.
52. Kellings K, Prusiner SB, Riesner D (1994) Nucleic acids in prion preparations: unspecific background or essential component? Philos Trans R Soc Lond B Biol Sci 343:425-430.
53. Kim JI, Cali I, Surewicz K, Kong Q, Raymond GJ, Atarashi R et al (2010) Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors. J Biol Chem 285:14083-14087.
54. Kim C, Haldiman T, Cohen Y, Chen W, Blevins J, Sy MS et al (2011) Protease-sensitive conform-ers in broad spectrum of distinct PrP structures in sporadic Creutzfeldt-Jakob disease are indicator of progression rate. PLoS Pathog 7:e1002242.
55. Kimberlin RH, Walker CA (1978) Pathogenesis of mouse scrapie: effect of route of inoculation on infectivity titres and dose-response curves. J Comp Pathol 88:39-47.
56. Kimberlin RH, Cole S, Walker CA (1987) Temporary and permanent modifications to a single strain of mouse scrapie on transmission to rats and hamsters. J Gen Virol 68:1875-1881.
57. King DJ, Safar JG, Legname G, Prusiner SB (2007) Thioaptamer interactions with prion proteins: sequence-specific and non-specific binding sites. J Mol Biol 369:1001-1014.
58. Kocisko DA, Come JH, Priola SA, Chesebro B, Raymond GJ, Lansbury PT Jr et al (1994) Cell-free formation of protease-resistant prion protein. Nature 370:471-474.
59. Kovacs GG, Head MW, Hegyi I, Bunn TJ, Flicker H, Hainfellner JA et al (2002)Immunohistochemistry for the prion protein: comparison of different monoclonal antibodies in human prion disease subtypes. Brain Pathol 12:1-11.
60. Legname G, Baskakov IV, Nguyen H-OB, Riesner D, Cohen FE, DeArmond SJ et al (2004)Synthetic mammalian prions. Science 305:673-676.
61. Legname G, Nguyen H-OB, Peretz D, Cohen FE, DeArmond SJ, Prusiner SB (2006) Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc Natl Acad Sci USA 103:19105-19110.
62. Lewis V, Hill AF, Klug GM, Boyd A, Masters CL, Collins SJ (2005) Australian sporadic CJD analysis supports endogenous determinants of molecular-clinical profiles. Neurology65:113-118.
63. Li J, Browning S, Mahal SP, Oelschlegel AM, Weissmann C (2010) Darwinian evolution of prions in cell culture. Science 327:869-872.
64. Mahal SP, Baker CA, Demczyk CA, Smith EW, Julius C, Weissmann C (2007) Prion strain discrimination in cell culture: the cell panel assay. Proc Natl Acad Sci USA 104:20908-20913.
65. Meyer N, Rosenbaum V, Schmidt B, Gilles K, Mirenda C, Groth D et al (1991) Search for a putative scrapie genome in purified prion fractions reveals a paucity of nucleic acids. J Gen Virol72:37-49.
66. Mishra RS, Basu S, Gu Y, Luo X, Zou WQ, Mishra R et al (2004) Protease-resistant human prion protein and ferritin are cotransported across Caco-2 epithelial cells: implications for species barrier in prion uptake from the intestine. J Neurosci 24:11280-11290.
67. Monari L, Chen SG, Brown P, Parchi P, Petersen RB, Mikol J et al (1994) Fatal familial insomnia and familial Creutzfeldt-Jakob disease: different prion proteins determined by a DNA polymorphism. Proc Natl Acad Sci USA 91:2839-2842.
68. Morales R, Abid K, Soto C (2007) The prion strain phenomenon: molecular basis and unprecedented features. Biochim Biophys Acta 1772:681-691.
69. Paravastu AK, Leapman RD, Yau WM, Tycko R (2008) Molecular structural basis for polymorphism in Alzheimer’s beta-amyloid fibrils. Proc Natl Acad Sci USA 105:18349-18354.
70. Parchi P, Castellani R, Capellari S, Ghetti B, Young K, Chen SG et al (1996) Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 39:767-778.
71. Parchi P, Capellari S, Chen SG, Petersen RB, Gambetti P, Kopp P et al (1997) Typing prion isoforms. Nature 386:232-233.
72. Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O et al (1999) Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46:224-233.
73. Pattison IH, Millson GC (1961) Scrapie produced experimentally in goats with special reference to the clinical syndrome. J Comp Pathol 71:101-108.
74. Peretz D, Scott M, Groth D, Williamson A, Burton D, Cohen FE et al (2001) Strain-specified relative conformational stability of the scrapie prion protein. Protein Sci 10:854-863.
75. Petkova AT, Ishii Y, Balbach JJ, Antzutkin ON, Leapman RD, Delaglio F et al (2002) A structural model for Alzheimer’s beta-amyloid fibrils based on experimental constraints from solid state NMR. Proc Natl Acad Sci USA 99:16742-16747.
76. Pirisinu L, Di Bari M, Marcon S, Vaccari G, D’Agostino C, Fazzi P et al (2011) A new method for the characterization of strain-specific conformational stability of protease-sensitive and protease-resistant PrP. PLoS One 5:e12723.
77. Piro JR, Supattapone S (2011) Photodegradation illuminates the role of polyanions in prion infec-tivity. Prion 5:49-51.
78. Piro JR, Harris BT, Nishina K, Soto C, Morales R, Rees JR et al (2009) Prion protein glycosylation is not required for strain-specific neurotropism. J Virol 83:5321-5328.
79. Polymenidou M, Stoeck K, Glatzel M, Vey M, Bellon A, Aguzzi A (2005) Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease. Lancet Neurol 4:805-814.
80. Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216:136-144.
81. Prusiner SB (1997) Prion diseases and the BSE crisis. Science 278:245-251.
82. Prusiner SB (1998a) Prions (Les Prix Nobel Lecture). In: Frângsmyr T (ed) Les Prix Nobel.Almqvist & Wiksell International, Stockholm, pp 268-323.
83. Prusiner S B (1998b) Prions. Proc Natl Acad Sci USA 95:13363-13383.
84. Prusiner SB (2001) Shattuck lecture-neurodegenerative diseases and prions. N Engl J Med 344:1516-1526.
85. Prusiner SB (ed) (2004) Prion biology and diseases. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
86. Prusiner SB, Cochran SP, Groth DF, Downey DE, Bowman KA, Martinez HM (1982) Measurement of the scrapie agent using an incubation time interval assay. Ann Neurol 11:353-358.
87. Prusiner SB, Scott M, Foster D, Pan K-M, Groth D, Mirenda C et al (1990) Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 63:673-686.
88. Prusiner SB, Scott MR, DeArmond SJ, Cohen FE (1998) Prion protein biology. Cell 93:337-348.
89. Prusiner SB, Tremblay P, Safar J, Torchia M, DeArmond SJ (1999a) Bioassays of prions. In: Prusiner SB (ed) Prion biology and diseases. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp 113-145.
90. Prusiner SB, Scott MR, DeArmond SJ, Carlson G (1999b) Transmission and replication of prions. In: Prusiner SB (ed) Prion biology and diseases. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp 147-190.
91. Prusiner SB, Scott MR, DeArmond SJ, Carlson G (2004a) Transmission and replication of prions. In: Prusiner SB (ed) Prion biology and diseases. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp 187-242.
92. Prusiner SB, Legname G, DeArmond SJ, Cohen FE, Safar J, Riesner D et al (2004b) Some strategies and methods for the study of prions. In: Prusiner SB (ed) Prion biology and diseases. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp 857-920.
93. Puoti G, Giaccone G, Rossi G, Canciani B, Bugiani O, Tagliavini F (1999) Sporadic CreutzfeldtJakob disease: co-occurrence of different types of PrP(Sc) in the same brain. Neurology53:2173-2176.
94. Safar JG (2012) Molecular pathogenesis of sporadic prion diseases in man. Prion 6:108-115.
95. Safar J, Roller PP, Gajdusek DC, Gibbs CJ Jr (1993) Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein. J Biol Chem 268:20276-20284.
96. Safar J, Roller PP, Gajdusek DC, Gibbs CJ Jr (1994) Scrapie amyloid (prion) protein has the conformational characteristics of an aggregated molten globule folding intermediate. Biochemistry33:8375-8383.
97. Safar J, Wille H, Itri V, Groth D, Serban H, Torchia M et al (1998) Eight prion strains have PrPSc molecules with different conformations. Nat Med 4:1157-1165.
98. Safar J, Cohen FE, Prusiner SB (2000) Quantitative traits of prion strains are enciphered in the conformation of the prion protein. Arch Virol Suppl 2000:227-235.
99. Safar JG, Scott M, Monaghan J, Deering C, Didorenko S, Vergara J et al (2002) Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice. Nat Biotechnol 20:1147-1150.
100. Safar JG, Kellings K, Serban A, Groth D, Cleaver JE, Prusiner SB et al (2005a) Search for a prion-specific nucleic acid. J Virol 79:10796-10806.
101. Safar JG, Geschwind MD, Deering C, Didorenko S, Sattavat M, Sanchez H et al (2005b) Diagnosis of human prion disease. Proc Natl Acad Sci USA 102:3501-3506.
102. Safar JG, DeArmond SJ, Kociuba K, Deering C, Didorenko S, Bouzamondo-Bernstein E et al(2005c) Prion clearance in bigenic mice. J Gen Virol 86:2913-2923.
103. Safar JG, Lessard P, Tamguney G, Freyman Y, Deering C, Letessier F et al (2008) Transmission and detection of prions in feces. J Infect Dis 198:81-89.
104. Safar JG, Giles K, Lessard P, Letessier F, Patel S, Serban A (2011) et al. Conserved properties of human and bovine prion strains on transmission to guinea pigs, Lab Invest Schoch G, Seeger H, Bogousslavsky J, Tolnay M, Janzer RC, Aguzzi A et al (2006) Analysis of prion strains by PrPSc profiling in sporadic Creutzfeldt-Jakob disease. PLoS Med 3:e14.
105. Scott M, Foster D, Mirenda C, Serban D, Coufal F, Walchli M et al (1989) Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell 59:847-857
106. Scott MR, Groth D, Tatzelt J, Torchia M, Tremblay P, DeArmond SJ et al (1997) Propagation of prion strains through specific conformers of the prion protein. J Virol 71:9032-9044.
107. Scott MR, Will R, Ironside J, Nguyen H-OB, Tremblay P, DeArmond SJ et al (1999) Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc Natl Acad Sci USA 96:15137-15142.
108. Scott M, Peretz D, Ridley RM, Baker HF, DeArmond SJ, Prusiner SB (2004) Transgenetic investigations of the species barrier and prion strains. In: Prusiner SB (ed) Prion biology and diseases. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp 435-482.
109. Scott MR, Peretz D, Nguyen H-OB, DeArmond SJ, Prusiner SB (2005).
110. Shirley BA (ed) (1995) Protein stability and folding: theory and practice. Humana, Totowa, NJ Stephenson DA, Chiotti K, Ebeling C, Groth D, DeArmond SJ, Prusiner SB et al (2000) Quantitative trait loci affecting prion incubation time in mice. Genomics 69:47-53.
111. Tamguney G, Giles K, Glidden DV, Lessard P, Wille H, Tremblay P et al (2008) Genes contributing to prion pathogenesis. J Gen Virol 89:1777-1788.
112. Tanaka M, Collins SR, Toyama BH, Weissman JS (2006) The physical basis of how prion conformations determine strain phenotypes. Nature 442:585-589.
113. Taraboulos A, Rogers M, Borchelt DR, McKinley MP, Scott M, Serban D et al (1990) Acquisition of protease resistance by prion proteins in scrapie-infected cells does not require asparagine-linked glycosylation. Proc Natl Acad Sci USA 87:8262-8266.
114. Taraboulos A, Jendroska K, Serban D, Yang S-L, DeArmond SJ, Prusiner SB (1992) Regional mapping of prion proteins in brains. Proc Natl Acad Sci USA 89:7620-7624.
115. Telling GC (2008) Transgenic mouse models of prion diseases. Methods Mol Biol 459:249-263.
116. Telling GC, Scott M, Hsiao KK, Foster D, Yang S-L, Torchia M et al (1994) Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein. Proc Natl Acad Sci USA 91:9936-9940.
117. Telling GC, Parchi P, DeArmond SJ, Cortelli P, Montagna P, Gabizon R et al (1996) Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 274:2079-2082
118. Tremblay P, Ball HL, Kaneko K, Groth D, Hegde RS, Cohen FE et al (2004) Mutant PrPSc con-formers induced by a synthetic peptide and several prion strains. J Virol 78:2088-2099.
119. Trevitt CR, Collinge J (2006) A systematic review of prion therapeutics in experimental models. Brain 129:2241-2265.
120. Tuzi NL, Cancellotti E, Baybutt H, Blackford L, Bradford B, Plinston C et al (2008) Host PrP glycosylation: a major factor determining the outcome of prion infection. PLoS Biol 6:e100.
121. Tzaban S, Friedlander G, Schonberger O, Horonchik L, Yedidia Y, Shaked G et al (2002) Proteasesensitive scrapie prion protein in aggregates of heterogeneous sizes. Biochemistry41:12868-12875.
122. Uro-Coste E, Cassard H, Simon S, Lugan S, Bilheude JM, Perret-Liaudet A et al (2008) Beyond PrP9res type 1/type 2 dichotomy in Creutzfeldt-Jakob disease. PLoS Pathog 4:e1000029.
123. Wadsworth JDF, Hill AF, Joiner S, Jackson GS, Clarke AR, Collinge J (1999) Strain-specific prion-protein conformation determined by metal ions. Nat Cell Biol 1:55-59.
124. Wang F, Wang X, Yuan CG, Ma J (2010) Generating a prion with bacterially expressed recombinant prion protein. Science 327:1132-1135.
125. Watts JC, Westaway D (2007) The prion protein family: diversity, rivalry, and dysfunction.
126. Zou WQ, Capellari S, Parchi P, Sy MS, Gambetti P, Chen SG (2003) Identification of novel proteinase K-resistant C-terminal fragments of PrP in Creutzfeldt-Jakob disease. J Biol Chem278:40429-40436.